Poliakoff Abba David 4
4 · CHAMPIONS ONCOLOGY, INC. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Poliakoff Abba David
Director
Transactions
- Exercise/Conversion
Common Stock
2021-01-19$3.21/sh+10,000$32,100→ 80,147 total - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $3.21Exp: 2022-10-31→ Common Stock (10,000 underlying) - Tax Payment
Common Stock
2021-01-19$11.53/sh+8,873$102,306→ 81,274 total - Exercise/Conversion
Common Stock
2021-01-19$5.43/sh+10,000$54,300→ 90,147 total - Exercise/Conversion
Common Stock
2021-01-19$1.59/sh+10,000$15,900→ 70,147 total - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $5.43Exp: 2024-11-04→ Common Stock (10,000 underlying) - Exercise/Conversion
Option to purchase Common Stock
2021-01-19−10,000→ 0 totalExercise: $1.59Exp: 2021-11-01→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]Represents a "net exercise" of outstanding stock options. The shares were withheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, Inc. common stock on January 19,2021.
- [F2]The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2016, February 1, 2017, May 1, 2017 and August 1, 2017 respectively.
- [F3]The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2017, February 1, 2018, May 1, 2018 and August 1, 2018, respectively.
- [F4]The options vest and are exercisable over a twelve month period, with vesting to occur on November 4, 2019, February 4, 2020, May 4, 2020 and August 4, 2020, respectively.